Millendo Therapeutics

About:

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.

Website: http://www.millendo.com/

Twitter/X: millendotx

Top Investors: New Enterprise Associates, Ann Arbor SPARK, Adams Street Partners, Frazier Healthcare Partners, 5AM Ventures

Description:

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

Total Funding Amount:

$192M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2011-01-01

Contact Email:

careers(AT)millendo.com

Founders:

Gary Hammer, Julia C. Owens

Number of Employees:

11-50

Last Funding Date:

2020-03-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai